Contact us

877-469-1TRM
424-208-8866

Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer

A Randomized Phase 3 Study of the Efficacy and Safety of Glufosfamide Compared With Fluorouracil (5-FU) in Patients With Metastatic Pancreatic Adenocarcinoma Previously Treated With Gemcitabine

For more information, please visit ClinicalTrials.gov

Patient Population Investigational Product(s) Phase Status
Pancreatic Glufosfamide III Open and Accruing